RxDoctor Payments Data

Victoria Sandler

Physician Assistant · Wilmington, DENPI 1437820156

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,462in general payments, 2019–2025

Across 194 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$449
  • AstraZeneca$371
  • Lilly USA, LLC$260
  • Novo Nordisk$240
  • Gilead$196
  • GSK$149
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$3,462100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,462 in reported general payments places this provider in the 90th percentile of 527 physician assistant providers in Delaware.

See all physician assistant providers in Delaware

Medicare billing

Part B allowed, 2024
$85,922
Medicare patients
420
Services billed
1,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide71$88,747
Nurtec OdtRimegepant Sulfate14$31,084
XareltoRivaroxaban19$30,791
OzempicSemaglutide21$25,200
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog18$22,580
EliquisApixaban16$20,219
TrulicityDulaglutide14$16,931
JardianceEmpagliflozin17$15,140
Tresiba Flextouch U-100Insulin Degludec12$4,001
Atorvastatin Calcium244$3,817
Novolog FlexpenInsulin Aspart15$3,753
Gabapentin133$2,919
Omeprazole121$1,885
Albuterol Sulfate HfaAlbuterol Sulfate36$1,865
Rosuvastatin Calcium67$1,639

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$260$105,67885 claims
PfizerNurtec Odt, Eliquis$92$51,30330 claims
Johnson & JohnsonXarelto$26$30,79119 claims
Novo NordiskOzempic$240$25,20021 claims
Boehringer IngelheimJardiance$132$15,14017 claims
AbbVieSynthroid$449$93726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 527 physician assistant providers in Delaware.

Other physician assistant in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →